A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.

ABSTRACT:

Background

Buprenorphine can be effective in a variety of community substance use treatment settings outside of methadone programs, including outpatient programs and medical practices. In these settings, it has been found to be effective in reducing opioid use and retaining patients in treatment. Despite its effectiveness and safety, it is rarely provided to individuals with opioid use disorders in probation and parole settings.

Methods

Male and female individuals under probation or parole supervision (N = 320) with histories of opioid use disorder will be enrolled in this randomized controlled trial. Participants will be randomized to one of two study arms: Buprenorphine Bridge Treatment (BBT): Participants will begin buprenorphine using the MedicaSafe dispensing device imm

SUBMITTER: Gordon MS 

PROVIDER: S-EPMC6436986 | biostudies-literature | 2019 Apr

REPOSITORIES: biostudies-literature